Acadian Asset Management
SCLN

Acadian Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Acadian Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,756,129
Closed -$19.3M – 1640
2017
Q2 		$19.3M Sell
1,756,129
-26,610
-1% -$266K 0.09% 209
2017
Q1 		$17.5M Sell
1,782,739
-136,433
-7% -$1.36M 0.08% 218
2016
Q4 		$20.7M Sell
1,919,172
-65,850
-3% -$658K 0.1% 189
2016
Q3 		$20.3M Sell
1,985,022
-397
-0% -$4.32K 0.1% 185
2016
Q2 		$25.9M Sell
1,985,419
-3,706
-0.2% -$48.6K 0.13% 154
2016
Q1 		$21.9M Buy
1,989,125
+31,595
+2% +$281K 0.11% 192
2015
Q4 		$18M Buy
1,957,530
+113,502
+6% +$950K 0.09% 217
2015
Q3 		$12.8M Sell
1,844,028
-94,800
-5% -$812K 0.07% 246
2015
Q2 		$19M Sell
1,938,828
-54,831
-3% -$499K 0.09% 202
2015
Q1 		$17.7M Sell
1,993,659
-31,295
-2% -$249K 0.08% 219
2014
Q4 		$17.7M Buy
2,024,954
+33,244
+2% +$269K 0.08% 217
2014
Q3 		$13.7M Buy
1,991,710
+760,575
+62% +$4.56M 0.07% 243
2014
Q2 		$6.48M Buy
1,231,135
+236,029
+24% +$1.15M 0.03% 332
2014
Q1 		$4.53M Sell
995,106
-222,714
-18% -$1.08M 0.02% 345
2013
Q4 		$6.13M Sell
1,217,820
-131,018
-10% -$630K 0.03% 311
2013
Q3 		$6.84M Buy
1,348,838
+754,675
+127% +$4.2M 0.04% 278
2013
Q2 		$2.95M Buy
+594,163
New +$2.83M 0.02% 350

Other funds holding SCLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Acadian Asset Management's SCLN Position: Q3 2017 in Review

Acadian Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2017, closing a stake of 1,756,129 shares — an estimated $19.3M sold.

Acadian Asset Management first reported a position in SCLN in Q2 2013 and held it in 17 quarters. The position peaked at $25.9M in Q2 2016. 129 funds tracked by Wall St. Rank hold SCLN as of Q3 2017.

  • Acadian Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • Acadian Asset Management sold 1,756,129 Sciclone Pharmaceuticals Inc shares in Q3 2017, an estimated $19.3M.
  • Acadian Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 17 quarters.
  • Acadian Asset Management's Sciclone Pharmaceuticals Inc position peaked at $25.9M in Q2 2016.
  • 129 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2017.

Based on Acadian Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.